Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
NCT06254261

A Study of RAY1225 in Participants With Obesity

Led by Guangdong Raynovent Biotech Co., Ltd · Updated on 2025-03-19

270

Participants Needed

1

Research Sites

95 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with Obesity. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.

CONDITIONS

Official Title

A Study of RAY1225 in Participants With Obesity

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a body mass index (BMI) of 28 kilogram per square meter (kg/m2) or 24 kg/m2 and previously diagnosed with at least one of the following weight related comorbidities: hypertension, dyslipidemia, obstructive sleep apnea, fatty liver disease, or HbA1c 5.7% and < 6.5%
  • Participants (including partners) must use reliable methods of contraception during the study and until 6 months following the last dose of investigational product
Not Eligible

You will not qualify if you...

  • Obesity induced by other endocrinologic disorders or monogenetic or syndromic forms of obesity
  • History of diabetes or hypoglycemia
  • Family or personal history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia (MEN) Syndrome type 2 or with thyroid nodules of unknown etiology found at screening and considered clinically significant by the investigator
  • Prior or planned surgical treatment for obesity (excluding liposuction or abdominoplasty if performed >1 year prior to screening)
  • Allergic constitution
  • Not suitable for subcutaneous injection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University People's Hospital

Beijingcun, Hebei, China

Actively Recruiting

Loading map...

Research Team

J

JI, professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here